search
Back to results

Novel Therapies for Essential Tremor

Primary Purpose

Essential Tremor

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
treatments for essential tremor
Sponsored by
US Department of Veterans Affairs
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Essential Tremor

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Diagnosis of essential tremor. Tremor rating scale score 3 or one or both upper extremities Unsatisfactory response to primidone or to propanolol Not taking tremor-inducing drug Able to comply with visits

Sites / Locations

  • VA Greater Los Angeles Healthcare System

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
July 3, 2001
Last Updated
January 20, 2009
Sponsor
US Department of Veterans Affairs
search

1. Study Identification

Unique Protocol Identification Number
NCT00018564
Brief Title
Novel Therapies for Essential Tremor
Official Title
Novel Therapies for Essential Tremor
Study Type
Interventional

2. Study Status

Record Verification Date
December 2004
Overall Recruitment Status
Completed
Study Start Date
October 2000 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
September 2003 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
US Department of Veterans Affairs

4. Oversight

5. Study Description

Brief Summary
This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.
Detailed Description
Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Essential Tremor

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Masking
Double
Allocation
Randomized

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
treatments for essential tremor

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Diagnosis of essential tremor. Tremor rating scale score 3 or one or both upper extremities Unsatisfactory response to primidone or to propanolol Not taking tremor-inducing drug Able to comply with visits
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fredricka Martin, Ph.D.
Facility Information:
Facility Name
VA Greater Los Angeles Healthcare System
City
Los Angeles
State/Province
California
ZIP/Postal Code
90073
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Novel Therapies for Essential Tremor

We'll reach out to this number within 24 hrs